跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AR-6
首页
药物
AR-6
AR-6
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
AR+ BREAST CANCER TREATMENT METHODS
EP 4066827 A1
申请人: ELLIPSES PHARMA LTD
优先权: 2016
EP
US
WO
8 件公开
[1, 2, 4] Triazolo [1, 5-A] Pyrimidine Derivatives as Chromatographic Adsorbent for the Selective Adsorption of Igg
US 2008220968 A1
申请人: GE HEALTHCARE BIO SCIENCES AB
优先权: 2005
CN
EP
US
WO
6 件公开
Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation
US 7253183 B2
申请人: JANSSEN PHARMACEUTICA NV
优先权: 2001
US
5 件公开
US 2004157882 A1
申请人: END DAVID WILLIAM
优先权: 2003
US
Aromatic amine derivative and organic electroluminescent element employing the same
US 2006061265 A1
申请人: KAWAMURA HISAYUKI
优先权: 2002
CN
EP
US
WO
4 件公开
LSD1 INHIBITOR AND PRMT6 INHIBITOR FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH GAIN-OF-FUNCTION OF ANDROGEN RECEPTOR (AR) AND/OR WITH OVEREXPRESSION OF AN AR COACTIVATOR
US 20260207649 A1
申请人: FOND TELETHON ETS 30%
优先权: 2022
CN
EP
US
WO
4 件公开
NOVEL EXPANDED PORPHYRINS AND PROCESS FOR THE SYNTHESIS THEREOF
EP 1306380 B1
申请人: JAPAN SCIENCE & TECH AGENCY
优先权: 2000
EP
US
WO
4 件公开
ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE
EP 2822687 B1
申请人: BIO RAD LABORATORIES
优先权: 2012
CN
EP
US
4 件公开
Indazole derivatives for the treatment of cancer
EP 1723954 A1
申请人: CARLSBAD TECHNOLOGY INC
优先权: 2005
CN
EP
US
3 件公开
Arylamine compound and synthetic method thereof
US 2007037011 A1
申请人: SEMICONDUCTOR ENERGY LAB
优先权: 2005
CN
US
WO
3 件公开
Organic Compound, Light-Emitting Device, Display Apparatus, And Electronic Appliance
US 20260223593 A1
申请人: SEMICONDUCTOR ENERGY LAB
优先权: 2023
CN
US
WO
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈